MoonLake Immunotherapeutics AG

16.07.2026

Moonlake Therapeutics raises USD 230 million in public offering (startupticker.ch)

04.02.2026

Two publications and an FDA fast track designation for Swiss biotechs (startupticker.ch)

07.11.2025

Development milestones and financing for biotech companies (startupticker.ch)

03.04.2025

MoonLake Immunotherapeutics secures up to $500 Million in non-dilutive financing (startupticker.ch)

09.01.2025

Positive developments at Swiss biotech companies (startupticker.ch)

27.05.2024

Biotechs record clinical trial successes (startupticker.ch)

01.05.2024

Triumphs and a setback in the biotech sector (startupticker.ch)

14.07.2023

Following encouraging Phase 2 results, MoonLake raises USD 400 million (startupticker.ch)

08.04.2022

MoonLake Immunotherapeutics goes public via SPAC (startupticker.ch)

06.04.2022

MoonLake Immunotherapeutics and Stalicla gear up for Phase 2 clinical studies (startupticker.ch)

14.10.2021

Zug-based biotech braces for IPO via SPAC (startupticker.ch)

12.08.2021

New executives take their seat (startupticker.ch)

11.05.2021

A newly launched biotech start-up with impressive study results in The Lancet (startupticker.ch)